Clinical Trials · NCT07534371
Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- West China Hospital
- Enrollment
- 500
- Start date
- Mar 2026
- Locations
- 1 site, China
- Primary endpoint
- PFS